miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells

Cancer Cell
Eric R LechmanJohn E Dick

Abstract

To investigate miRNA function in human acute myeloid leukemia (AML) stem cells (LSC), we generated a prognostic LSC-associated miRNA signature derived from functionally validated subpopulations of AML samples. For one signature miRNA, miR-126, high bioactivity aggregated all in vivo patient sample LSC activity into a single sorted population, tightly coupling miR-126 expression to LSC function. Through functional studies, miR-126 was found to restrain cell cycle progression, prevent differentiation, and increase self-renewal of primary LSC in vivo. Compared with prior results showing miR-126 regulation of normal hematopoietic stem cell (HSC) cycling, these functional stem effects are opposite between LSC and HSC. Combined transcriptome and proteome analysis demonstrates that miR-126 targets the PI3K/AKT/MTOR signaling pathway, preserving LSC quiescence and promoting chemotherapy resistance.

References

Dec 24, 1993·Science·S van den Heuvel, E Harlow
Apr 16, 2004·Cell·Shengjun Ren, Barrett J Rollins
Dec 7, 2005·The Journal of Experimental Medicine·Emmanuelle PasseguéIrving L Weissman
Oct 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·Zejuan LiJianjun Chen
Jul 18, 2009·Nature Reviews. Genetics·Brian D Brown, Luigi Naldini
Feb 26, 2010·Nature Reviews. Immunology·Andreas TrumppAnne Wilson
Apr 29, 2010·Current Hematologic Malignancy Reports·Guido MarcucciClara D Bloomfield
Jul 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Shangqin GuoDavid T Scadden
Jul 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Ryan M O'ConnellDavid Baltimore
Nov 19, 2010·Science Translational Medicine·Bernhard GentnerLuigi Naldini
Dec 2, 2010·Proceedings of the National Academy of Sciences of the United States of America·A G Lisa OoiChristopher Y Park
Apr 13, 2011·Blood·Frederik W van DelftMel Greaves
Jul 16, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ipsita Dey-GuhaSridhar Ramaswamy
Aug 30, 2011·Nature Medicine·Kolja EppertJohn E Dick
Sep 9, 2011·Nature Medicine·Mel Greaves
Nov 9, 2011·Molecular Cancer Research : MCR·Shin HamadaTooru Shimosegawa
May 1, 2012·Cell·Margaret S Ebert, Phillip A Sharp
Nov 13, 2012·Cell Stem Cell·Eric R LechmanLuigi Naldini
Mar 29, 2013·The New England Journal of Medicine·Harry L A JanssenMichael R Hodges
Dec 18, 2013·The Journal of Clinical Investigation·Chinavenmeni S VeluH Leighton Grimes
Jan 24, 2014·Advances in Hematology·Ram Babu UndiRavi Kumar Gutti
Mar 13, 2014·Cell Stem Cell·Antonija Kreso, John E Dick
Feb 24, 2015·Cell Stem Cell·Elisa LaurentiJohn E Dick
Jun 10, 2015·Molecular and Cellular Therapies·Lars FranseckyClaudia D Baldus

❮ Previous
Next ❯

Citations

Feb 10, 2016·Cancer Cell·Simon Raffel, Andreas Trumpp
Apr 17, 2016·International Journal of Hematology·Sha HaoTao Cheng
Apr 29, 2016·Nature Reviews. Immunology·Arnav Mehta, David Baltimore
May 3, 2016·Current Opinion in Hematology·Marie PouzollesValérie S Zimmermann
Sep 10, 2016·Medicine·William H Matsui
Dec 16, 2016·International Journal of Molecular Sciences·Armin ZebischHeinz Sill
Feb 6, 2017·Blood·Daniel Thomas, Ravindra Majeti
Feb 2, 2017·The Journal of Clinical Investigation·Satoru Osuka, Erwin G Van Meir
May 6, 2017·Stem Cells International·Pedro M Aponte, Andrés Caicedo
Feb 1, 2017·Molecular Cancer·Kodappully Sivaraman SiveenRamzi M Mohammad
Jul 1, 2017·Cancers·Tania Martiáñez CanalesLinda Smit
Feb 7, 2018·International Journal of Molecular Sciences·Stefania TrinoLuciana De Luca
Jul 8, 2017·Antioxidants & Redox Signaling·Matilde E LleonartAlex Lyakhovich
Jul 14, 2016·F1000Research·Hector Mayani
May 12, 2019·Journal of Clinical Medicine·Vitalba RuggieriSimona Laurino
Mar 30, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hao ZengJunping Wang
Aug 3, 2019·British Journal of Haematology·Peter HoklandMarie Bill
Jan 10, 2018·Development·Delong MengJenna L Jewell
Feb 9, 2019·Renal Failure·Yasemin Coskun YavuzIdris Baydar
Jan 8, 2020·Nature Reviews. Cancer·David VetrieMhairi Copland
Jan 15, 2020·Annals of Hematology·Mingyu LiHongzai Guan
Sep 19, 2019·Médecine sciences : M/S·Mélanie Bellina
Jul 25, 2017·The Journal of Experimental Medicine·Mona KhalajChristopher Y Park
Aug 23, 2016·Current Stem Cell Reports·Christine Roden, Jun Lu
Dec 21, 2016·Frontiers in Pharmacology·Zhijie XuZhicheng Gong
Mar 16, 2018·Journal of Translational Medicine·Qiu-Ling MaJie Jin
May 28, 2019·Journal of Hematology & Oncology·Yan LiuLin Fu
May 18, 2020·Nature Reviews. Cancer·Masayuki YamashitaEmmanuelle Passegué
Feb 1, 2017·Molecular Cancer·Xuefei WangJi-Long Chen

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
Xenografts

Software Mentioned

GSEA

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.